Other languages ImmunityBio, Inc.

Equities

IBRX

US45256X1037

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
6.1 ^USD	+0.16%		-4.98%	+21.51%

May. 09	ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 07	ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09
ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment	May. 07
ImmunityBio, Inc. Completes GMP Drug Substance Manufacturing Sufficient for 170,000 Doses of ANKTIVA®	May. 07
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Monday; Palantir to Advance, Trump Media & Technology Group to Decline	May. 06
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Friday; ImmunityBio to Advance, Boeing to Decline	May. 03
Immunitybio, Inc., Serum Institute of India Agree on an Exclusive Arrangement for Global Supply of Bacillus Calmette-Guerin Across All Cancer Types	May. 02
Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Tuesday; MicroStrategy, Tesla to Decline	Apr. 30
Social Buzz: Wallstreetbets Stocks Mostly Higher Premarket Monday; Tesla, ImmunityBio to Advance	Apr. 29
ImmunityBio, Inc. Announces Positive Overall Survival Results of Anktiva Combined with Checkpoint Inhibitors in Non-Small Cell Lung Cancer	Apr. 25
Upcoming Big Tech Earnings Buoy Exchange-Traded Funds, Equity Futures Pre-Bell Tuesday	Apr. 23
IN DIRETTA DAI MERCATI: Netweek, Ence Energia, Enel, OVS, Sogefi, Telecom Italia, ASML, Novartis, Airbus, Apple, Nvidia, Boeing...	Apr. 23
C'est parti pour les publications de résultats à la chaîne	Apr. 23
En Direct des Marchés : Renault, SAP, Sanofi, TotalEnergies, Novartis, Legrand, Tapestry, OVH...	Apr. 23
EN DIRECTO DESDE LOS MERCADOS: Enagas, Ence Energia, Acerinox, Naturgy, Endesa, Telefónica, Novartis, Apple, Nvidia, Boeing...	Apr. 23
Bolsa de Madrid: Publicación consecutiva de resultados	Apr. 23
US FDA approves ImmunityBio's bladder cancer therapy	Apr. 22
ImmunityBio, Inc. Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer	Apr. 22
U.S. FDA approves ImmunityBio's bladder cancer therapy	Apr. 22
ImmunityBio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 19
ImmunityBio Announces Data from A Phase 1 Pilot Study	Mar. 05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ImmunityBio, Inc.

Equities

IBRX

US45256X1037

Other languages

Filters